Published on in Vol 23, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29558, first published .
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey

Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey

Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey

Journals

  1. Inojosa H, Proschmann U, Akgün K, Ziemssen T. The need for a strategic therapeutic approach: multiple sclerosis in check. Therapeutic Advances in Chronic Disease 2022;13 View
  2. Dimitriou N, Meuth S, Martinez-Lapiscina E, Albrecht P, Menge T. Treatment of Patients with Multiple Sclerosis Transitioning Between Relapsing and Progressive Disease. CNS Drugs 2023;37(1):69 View
  3. Ziemssen T, Vandercappellen J, Jordan Mondragon V, Giovannoni G. MSProDiscuss™ Clinical Decision Support Tool for Identifying Multiple Sclerosis Progression. Journal of Clinical Medicine 2022;11(15):4401 View
  4. Liao G, Huang T, Wong M, Shyu Y, Ho L, Wang C, Cheng T, Teng C. Enhancing Nurse–Robot Engagement: Two-Wave Survey Study. Journal of Medical Internet Research 2023;25:e37731 View
  5. Theodorsdottir A, Larsen P, Nielsen H, Illes Z, Ravnborg M. Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis. Acta Neurologica Scandinavica 2022;145(3):332 View
  6. Giovannoni G, Alvarez E, Tutton E, Hoffmann O, Xu Y, Vermersch P, Oreja-Guevara C, Trojano M, Gold R, Robles-Cedeño R, Khwaja M, Stadler B, Vandercappellen J, Ziemssen T. Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosis. DIGITAL HEALTH 2023;9 View
  7. Patel S, Rafferty S, Aquino L, Chadha S, Ginocchio R, Cyr B, Fedorko J, Imitola J. VISIBL-MS: A bilingual educational framework to increase awareness of early multiple sclerosis. Multiple Sclerosis Journal 2024;30(4-5):585 View
  8. Krieger S, Cook K, Hersh C. Understanding multiple sclerosis as a disease spectrum: above and below the clinical threshold. Current Opinion in Neurology 2024;37(3):189 View
  9. Papukchieva S, Kahn M, Eberl M, Friedrich B, Joschko N, Ziemssen T. Data on Ocrelizumab Treatment Collected by MS Patients in Germany Using Brisa App. Journal of Personalized Medicine 2024;14(4):409 View
  10. Demuth S, Ed‐Driouch C, Dumas C, Laplaud D, Edan G, Vince N, De Sèze J, Gourraud P. Scoping review of clinical decision support systems for multiple sclerosis management: Leveraging information technology and massive health data. European Journal of Neurology 2024 View